Bone Marrow Transplant

If you or someone in your family has been diagnosed with leukemia, aplastic anemia, lymphoma, multiple myeloma, thalassemia, or sickle cell disease, your doctor has likely told you that a bone marrow transplant is the best available path to remission or cure. What they may not have been able to offer is the procedure itself. Across much of Africa and the Middle East, dedicated bone marrow transplant units with HEPA-filtered sterile rooms, HLA typing laboratories, and trained hemato-oncologists remain rare. In many countries, there is simply no programme performing these transplants at all. Patients in this situation are referred abroad — and for the majority, India is where they go.

A bone marrow transplant, also called a stem cell transplant, replaces your damaged or diseased bone marrow with healthy stem cells. These cells can come from your own body (an autologous transplant), a matched family donor (allogeneic), a half-matched donor such as a parent or sibling (haploidentical), or an unrelated donor registry. The type recommended depends on your diagnosis, the stage of your disease, and whether a matching donor is available. Most patients travel to India for either autologous or allogeneic transplants for conditions including leukemia, aplastic anemia, sickle cell disease, and thalassemia.

In India, the cost of a bone marrow transplant ranges from approximately $14,000 USD for an autologous procedure to $28,000 USD for a fully matched allogeneic transplant at a private hospital. Haploidentical transplants, which are used when no fully matched donor exists, range from $32,000 to $38,000 USD. This is a fraction of the cost at private hospitals in the Gulf states or South Africa, and dramatically less than equivalent care in Western countries. The difference comes down to procedure volumes and healthcare infrastructure costs in India, not to any reduction in the standard of care. India performs approximately 3,000 bone marrow transplants per year as of 2026, a volume that drives clinical expertise and keeps costs structured around outcomes rather than rarity.

India's leading BMT centres — Fortis Memorial Research Institute in Gurugram, BLK-Max Super Specialty Hospital in New Delhi, Apollo Hospitals across Delhi, Chennai, and Hyderabad, and Medanta The Medicity in Gurugram — are JCI-accredited and operate dedicated HEPA-filtered transplant units essential for protecting immunocompromised patients. Apollo Hospitals has completed over 1,500 bone marrow transplants with a success rate of 90% and above. Medanta performs over 400 BMTs annually, with 100-day survival rates for standard-risk allogeneic transplants exceeding 80%. Fortis Memorial Research Institute houses South Asia's largest BMT unit with 50 HEPA-filtered beds and a dedicated multidisciplinary team including hemato-oncologists, infectious disease specialists, and nutritionists.

One factor that distinguishes India for international patients is HLA typing capability. All major transplant centres have accredited in-house HLA laboratories and connections to both Indian and international donor registries, including DKMS. For patients without a fully matched sibling donor, haploidentical transplant programmes at Fortis and BLK-Max have produced outcomes comparable to matched-donor transplants — an option that is simply not available locally for most patients travelling from Africa or the Middle East.

MediVenza arranges your complete journey: medical visa invitation letter, hospital selection and booking, airport pickup, accommodation for you and your accompanying family member, interpreter support during consultations, and full documentation for your follow-up doctor when you return home. Our coordinator stays with you from your first message to your post-return follow-up.

Want a clear picture before you decide?

Send your medical reports to [email protected] or WhatsApp +919899655596. Our team will review your case and advise on costs, timeline, and next steps within 24 hours. There is no obligation.

Send your medical reports to [email protected] or WhatsApp +919899655596 for assessment within 24 hours.

How Bone Marrow Transplant Is Performed in India

The transplant process begins two to four weeks before the stem cell infusion itself. Your transplant team will first confirm your HLA type and, where an allogeneic transplant is planned, verify your donor's compatibility. Specialist centres including Fortis, BLK-Max, Apollo, and Medanta carry out all pre-transplant work in their dedicated units. You will be admitted to a sterile HEPA-filtered room, which protects you from airborne infection during the period when your immune system is most vulnerable.

• Conditioning: You receive high-dose chemotherapy, and sometimes radiation, over four to seven days. This destroys the diseased bone marrow and suppresses your immune system to prevent rejection.
• Stem cell infusion: Healthy stem cells are infused through a central venous catheter — a procedure similar to a blood transfusion, taking around one to two hours. No surgery is required at this stage.
• Engraftment monitoring: Over the following two to four weeks, the transplant team monitors daily blood counts to confirm the new stem cells are producing healthy blood cells. Infection control and supportive medications are given throughout.
• Discharge and recovery stay: Once engraftment is confirmed and your condition is stable, you are discharged from the hospital. You will need to remain nearby for several additional weeks of close outpatient monitoring before travelling home.

Total time in India is typically 45 to 90 days depending on your transplant type and recovery. MediVenza arranges family accommodation close to the hospital, and an interpreter is available for all consultations throughout your stay.

Recovery After Bone Marrow Transplant: What to Expect

Most patients spend three to five weeks in the hospital following their transplant. You will not be cleared to travel home until your blood counts have stabilised, engraftment is confirmed, and your transplant team is satisfied that your immune function is sufficient for the journey. For autologous transplants, this is typically around four to six weeks after the infusion. Allogeneic transplants generally require a longer monitoring period of six to ten weeks in India before you are cleared to fly.

Recovery After Returning Home

Full immune recovery takes three to twelve months after a bone marrow transplant. In the first three months at home, you will need to continue immunosuppressant medications, attend regular blood tests, and avoid crowded public spaces. Your transplant team in India provides a detailed discharge summary and medication plan written for your local doctor to follow. This document covers all post-transplant medications, warning signs to watch for, and a recommended follow-up schedule.

Remote consultations with your India-based transplant team are available via WhatsApp and video call throughout your recovery period. This allows your local doctor to communicate directly with your specialist if your blood results raise concerns.

MediVenza coordinates the transfer of all documentation, including discharge summaries, lab results, and treatment records, to ensure your recovery at home is supported from the moment you land.